Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:37 PM
Ignite Modification Date:
2025-12-24 @ 4:37 PM
NCT ID:
NCT01940666
Eligibility Criteria:
Inclusion Criteria:
* Hyperandrogenic women who were classified into four groups:
* Total testosterone (TT),
* Androstenedione (A4),
* Free androgen index (FAI),
* and Dehydroepiandrosterone sulphate(DHEA-S).
* According to abnormally elevated androgen measures each above its cut-off value, and non hyperandrogenic women (who had all androgens below their cut-off values)
Exclusion Criteria:
* None of the women studied had
* Hypogonadotropic hypogondism,
* Hyperprolactinemia,
* Congenital adrenal hyperplasia,
* Premature ovarian failure,
* Androgen-secreting tumors,
* Cushing's syndrome,
* or any other endocrine or systemic disease that may affect the reproductive function,
* or any disorders of the uterus (e.g. Asherman's syndrome and Mullerian genesis) and chromosomal anomalies (e.g. Turner's syndrome).
* In addition, we excluded females who had
* Experienced menarche less than three years preceding the study start,
* or who had day 3 FSH \> 15 mIU/ml, as well as women with insufficient clinical/biochemical records,
* and women with ovarian cysts or tumors in an ultrasonographic examination.
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
13 Years
Maximum Age:
48 Years
Study:
NCT01940666
Study Brief:
Protocol Section:
NCT01940666